The global respiratory syncytial virus vaccine and antibody pipeline market size was valued at USD x million in 2023 and is poised to grow at a significant CAGR of 27.1% during the forecast period 2024-30. It also includes market size and projection estimations for each of the five major regions from 2024 to 2030. The research report includes historical data, trending features, and market...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian